Ceva Animal Health, LLC has announced its new status as a Platinum level sponsor of the Companion Animal Parasite Council (CAPC). This sponsorship highlights Ceva's commitment to educating veterinarians and the public about the prevention and control of parasitic infections in companion animals.
Read More
Dr. Christopher Carpenter, Executive Director of CAPC, expressed gratitude for Ceva’s leadership, noting, "We greatly appreciate their support and look forward to collaborating with them to engage and educate veterinary teams and the public through CAPC’s maps, forecasts and guidelines."
In 2016, CAPC updated its Canine Heartworm Guidelines to include information on reducing heartworm infection risk by limiting exposure to mosquitoes, which can be aided by mosquito repellents approved for dogs.
Craig Wallace, CEO of Ceva Animal Health, commented on their partnership with CAPC, stating, "These changes in the CAPC Guidelines represent a significant step forward. We enthusiastically enter into our partnership with CAPC helping them achieve their vision of ‘Every Pet Tested and Protected’ fighting both heartworms and the vectors carrying them."
The Companion Animal Parasite Council is an independent non-profit organization comprised of experts from various fields, including parasitology and veterinary medicine, dedicated to providing accurate information for effective control of internal and external parasites. Established in 2002, CAPC aims to assist veterinary professionals and pet owners in developing best practices to protect pets and reduce the risk of zoonotic diseases.
Ceva Animal Health's product range includes parasiticides like Vectra® and Catego™, as well as pheromone products such as Adaptil® and Feliway®. The company is based in Lenexa, Kansas, with its parent organization, Ceva Santé Animale, headquartered in Libourne, France, and focuses on the development and marketing of veterinary pharmaceutical products and vaccines.